Detalhe da pesquisa
1.
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma.
Blood
; 140(21): 2248-2260, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35839452
2.
A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19.
Am J Respir Crit Care Med
; 207(3): 261-270, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36099435
3.
Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
Br J Haematol
; 202(2): 248-255, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37129856
4.
Mesenchymal stromal cell therapy for acute respiratory distress syndrome due to coronavirus disease 2019.
Cytotherapy
; 24(8): 835-840, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35649958
5.
Myocardial Amyloid Quantification with Look-Locker Magnetic Resonance Sequence in Cardiac Amyloidosis. Diagnostic Accuracy in Clinical Practice and Histological Validation.
J Card Fail
; 24(2): 78-86, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28801077
6.
Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 21(7): 1155-66, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25769794
7.
Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment.
BMC Cancer
; 15: 444, 2015 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26025442
8.
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma.
J Immunother Cancer
; 12(4)2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38609316
9.
CD19-Targeted Chimeric Antigen Receptor T-cell Therapy for Concomitant Diffuse Large B-cell Lymphoma and Multiple Myeloma.
Cureus
; 15(9): e44542, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37790017
10.
Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients.
J Exp Med
; 201(9): 1503-17, 2005 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-15867097
11.
Combining FDG-PET/CT with laboratory data yields superior results for prediction of relapse in multiple myeloma.
Eur J Haematol
; 86(4): 289-98, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21198866
12.
Vigorous premalignancy-specific effector T cell response in the bone marrow of patients with monoclonal gammopathy.
J Exp Med
; 198(11): 1753-7, 2003 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14638846
13.
Non-myeloablative conditioning and allogeneic transplantation for multiple myeloma.
Am J Hematol
; 85(4): 249-54, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20162541
14.
Bendamustine With Dexamethasone in Relapsed/Refractory Systemic Light-Chain Amyloidosis: Results of a Phase II Study.
J Clin Oncol
; 38(13): 1455-1462, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32083996
15.
Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization.
Cytotherapy
; 11(4): 457-63, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19499401
16.
CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease.
Clin Lymphoma Myeloma Leuk
; 23(10): 772-778, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37263876
17.
Graft versus host disease after stem cell allotransplantation with low-dose total body irradiation, fludarabine, and antithymocyte globulin.
Transplantation
; 84(5): 598-604, 2007 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17876272
18.
Phase 1/2 study of ixazomib with cyclophosphamide and dexamethasone in newly diagnosed AL amyloidosis.
Blood Adv
; 6(18): 5436-5439, 2022 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35858371
19.
COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter.
Leukemia
; 34(10): 2809-2812, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32801310
20.
Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.
Cancer Immun
; 3: 9, 2003 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-12875607